Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

NCT02935595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Ketamine

Sponsor

The University of Texas Health Science Center, Houston